MedTrace Logo

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

NCT06902493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 664

Last updated 2025-03-30

No results posted yet for this study

Summary

The primary objective of this study is to investigate whether using SGLT2i may be associated with decreased incidence of sepsis-induced AKI or not.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Jazan

    lead OTHER_GOV

Principal Investigators

  • Mohammed Alshrahili, MSc · Armed Forces Hospitals, Southern Region, Saudi Arabia

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06902493 on ClinicalTrials.gov